Financials

Company Profile

Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.

Employees

Sector

04-29	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02/10/25	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/04/25	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
03/04/25	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
29/04/24	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
29/04/23	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
29/07/22	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022	CI
11/04/22	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2021	CI
16/04/21	Global markets live: Daimler, GSK, Mattel
23/12/20	Eurofins Cerep : Launches PCR COVID-19 Self-Test In Germany, Spain	MT
24/09/20	Eurofins-Cerep Sa Reports Earnings Results for the Half Year Ended June 30, 2020	CI
29/07/18	Eurofins Cerep SA acquired KVI-Plusz.	CI
03/08/15	Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, completed the acquisition of a majority stake in Bioaccess S.A.	CI

18/09/25	Eurofins Cerep : annonce ses résultats du 1er semestre 2025	PU
12/04/23	Eurofins Cerep : annonce ses résultats 2022	PU

04-10	Eurofins Cerep : annonce ses résultats 2025
01/10/25	Eurofins Cerep : Rapport Financier Semestriel - Semestre clos le 30 juin 2025
09/05/25	Eurofins Cerep : Rapport annuel 2024
03/04/25	Eurofins Cerep : annonce ses résultats du 1er semestre 2023
03/04/25	Eurofins Cerep : annonce ses résultats 2024

Director	Title	Age	Since
Paul Ratcliffe CHM	Chairman	-	10/08/2023
Damien Vielliard BRD	Director/Board Member	-	22/05/2024
Rodolphe Simonot BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EUROFINS-CEREP	+0.01%	+4,900.50%	-	-	93.68M
LONZA GROUP AG	+2.61%	+1.91%	+1.70%	+13.91%	47.88B
REVOLUTION MEDICINES, INC.	-1.60%	-1.29%	+385.56%	+603.70%	39.09B
BEONE MEDICINES AG	-0.98%	+2.68%	+11.10%	+45.34%	36.75B
IQVIA HOLDINGS INC.	+1.90%	+22.79%	+25.18%	+9.47%	40.55B
CELLTRION, INC.	+1.47%	+4.90%	+6.48%	+43.52%	27.96B
ASCENDIS PHARMA A/S	-0.94%	-1.23%	-	-	16.77B
MEDPACE HOLDINGS, INC.	+2.44%	+10.02%	+29.11%	+129.56%	15.94B
EUROFINS SCIENTIFIC SE	+0.18%	-1.46%	+4.92%	+10.14%	13.55B
ICON PUBLIC LIMITED COMPANY	-1.14%	+6.94%	-6.05%	-29.33%	13.81B
Average	+0.39%	+4.66%	+57.25%	+103.29%	28.03B
Weighted average by Cap.	+0.61%	+5.06%	+73.07%	+124.52%